Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients

Saved in:
Bibliographic Details
Published in:Endocrine Journal
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553113257902080
collection WordPress RSS
FRELIP Feed Integration
container_title Endocrine Journal
description
discipline_display Endocrinology
discipline_facet Endocrinology
format Online Article
RSS Article
genre Journal Article
id rss_article:73715
institution FRELIP
journal_source_facet Endocrine Journal
last_indexed 2026-06-20T21:31:51.751Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
Endocrinology
General
Endocrinology
sub_discipline_display General
sub_discipline_facet General
subject_display Endocrinology
General
Endocrinology
subject_facet Endocrinology
General
Endocrinology
title Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
title_alt Eficacia y seguridad de dabrafenib más trametinib en carcinoma tiroideo avanzado con mutación BRAFV600E: experiencia del mundo real en 37 pacientes
Efficacité et sécurité du dabrafénib plus tramétinib dans le carcinome thyroïdien avancé muté BRAFV600E : expérience réelle chez 37 patients
Eficácia e segurança de dabrafenibe mais trametinibe em carcinoma avançado de tireoide mutado BRAFV600E: experiência do mundo real em 37 pacientes
title_auth Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
title_es_txt Eficacia y seguridad de dabrafenib más trametinib en carcinoma tiroideo avanzado con mutación BRAFV600E: experiencia del mundo real en 37 pacientes
title_fr_txt Efficacité et sécurité du dabrafénib plus tramétinib dans le carcinome thyroïdien avancé muté BRAFV600E : expérience réelle chez 37 patients
title_full Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
title_fullStr Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
title_full_unstemmed Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
title_pt_txt Eficácia e segurança de dabrafenibe mais trametinibe em carcinoma avançado de tireoide mutado BRAFV600E: experiência do mundo real em 37 pacientes
title_short Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
title_sort efficacy and safety of dabrafenib plus trametinib in brafv600e-mutated advanced thyroid carcinoma: real world experience in 37 patients
topic Endocrinology
General
Endocrinology
url https://pubmed.ncbi.nlm.nih.gov/42128849/?utm_source=Chrome&utm_medium=rss&utm_campaign=None&utm_content=1FwYT_rsr_VoWURnMTN9cD1_cY0UhV89NzrhQ2a8RsBDYTO9SQ&fc=None&ff=20260606104015&v=2.20.0